Nutritional anemia from park textbook of social and preventive medicine, be in detail

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the content needed. Let me compile the comprehensive answer from Park's Textbook.

Nutritional Anaemia - Park's Textbook of Preventive and Social Medicine


Definition

Nutritional anaemia is a disease syndrome caused by malnutrition in its widest sense. WHO defines it as:
"A condition in which the haemoglobin content of blood is lower than normal as a result of a deficiency of one or more essential nutrients, regardless of the cause of such deficiency."
The most frequent cause is iron deficiency, followed less commonly by folate or vitamin B12 deficiency.
  • Park's Textbook of Preventive and Social Medicine, p. 738

Diagnosis of Anaemia - WHO Cut-off Points (Table 12)

GroupHaemoglobin (g/dl)MCHC (%)
Adult males1334
Adult females, non-pregnant1234
Adult females, pregnant1134
Children, 6 months to 6 years1134
Children, 6 to 14 years1234
  • Hb 10-11 g/dl = Early anaemia
  • Hb < 10 g/dl = Marked anaemia
  • MCHC < 34% indicates hypochromic red cells, seen in iron deficiency anaemia

Stages of Iron Deficiency

Three sequential stages have been described:
  1. First stage - Decreased storage of iron with no other detectable abnormalities (serum ferritin falls).
  2. Second stage (Latent iron deficiency) - Iron stores exhausted but anaemia has not yet occurred. Serum ferritin is low; transferrin saturation falls from normal 30% to less than 15%. This is the most widely prevalent stage in India.
  3. Third stage (Overt iron deficiency / Iron deficiency anaemia) - Decrease in circulating haemoglobin due to impaired haemoglobin synthesis. Full picture of anaemia.

Evaluation of Iron Status

Four key laboratory parameters:
(a) Haemoglobin concentration - Relatively insensitive index of depletion since anaemia is a late manifestation of iron deficiency.
(b) Serum iron - More useful than Hb. Normal range: 0.80-1.80 mg/L. Values below 0.50 mg/L indicate probable iron deficiency.
(c) Serum ferritin - The single most sensitive tool for evaluating iron status. Reflects the size of iron stores. Values below 10 mcg/L indicate absence of stored iron.
(d) Serum transferrin saturation - Should be above 16%. Normal value is 30%.

The Problem - Magnitude

World

Nutritional anaemia is a worldwide problem with the highest prevalence in developing countries. It affects:
  • Nearly two-thirds of pregnant women in developing countries
  • About one-half of non-pregnant women in developing countries
  • Even in developed countries, an estimated 4-12% of women of child-bearing age have anaemia

India

Iron deficiency anaemia is the most widespread micronutrient deficiency in India, affecting all age groups irrespective of gender, caste, creed, or religion. High-risk groups include:
  • Women in the reproductive age group (15-49 years)
  • Children (6-35 months)
  • Low socio-economic strata
Key statistics:
  • 72.7% of children up to 3 years in urban areas are anaemic
  • 81.2% of children up to 3 years in rural areas are anaemic
  • Prevalence increased from 74.2% (1998-99) to 79.2% (2005-06)
  • Bihar had the highest prevalence (87.6%), Nagaland the lowest (44.3%)
  • Adolescent girls: prevalence 72.6% (DLHS 2002-04); severe anaemia was 21.1%
  • 19% of maternal deaths in India are attributable to anaemia

Aetiology / Causes

Iron deficiency arises through two main mechanisms:
  1. Inadequate intake or poor bioavailability of dietary iron. Although diets may contain seemingly adequate amounts of iron, less than 5% is absorbed from the gut. Poor bioavailability is a major reason for widespread iron deficiency.
  2. Excessive losses of iron from the body - especially in women due to menstrual losses, repeated pregnancies at close intervals, and blood loss during delivery.
Other contributing factors:
  • Malaria and hookworm infestations - major parasitic contributors to anaemia
  • Women who have closely-spaced pregnancies become anaemic due to the combined demands of pregnancy and blood loss at each delivery
  • Megaloblastic anaemia (due to folate/B12 deficiency) occurs in pregnant women from poor income groups; sub-clinical folate deficiency found in ~30% of pregnant women in rural North India

Detrimental Effects

Anaemia causes harm in three important areas:
(a) Pregnancy outcomes:
  • Increases risk of maternal and foetal mortality and morbidity
  • 19% of maternal deaths in India are due to anaemia
  • Associated with abortions, premature births, postpartum haemorrhage, and low birth weight
(b) Infection:
  • Anaemia can be caused or aggravated by parasitic diseases (malaria, intestinal parasites)
  • Iron deficiency impairs cellular immune responses and increases susceptibility to infection
  • Other functional disturbances: impaired cell-mediated immunity, reduced resistance to infection, increased morbidity and mortality
(c) Work capacity:
  • Even mild anaemia causes significant impairment of maximal work capacity
  • The more severe the anaemia, the greater the reduction in work performance and productivity
  • Major economic consequence for developing countries

Interventions and Management

Initial Assessment

Haemoglobin estimation is done to assess severity:
  • Hb < 10 g/dl (Severe): High-dose iron or blood transfusion may be necessary; refer to nearest PHC
  • Hb 10-12 g/dl: Medical interventions below

(1) Iron and Folic Acid Supplementation

The National Nutritional Anaemia Prophylaxis Programme was launched by the Government of India during the Fourth Five Year Plan. It is based on daily supplementation with iron and folic acid tablets to prevent mild and moderate anaemia. Target "at-risk" groups: pregnant women, lactating mothers, and children under 12 years.
Eligibility criteria: Hb 10-12 g/dl → daily iron + folic acid supplementation; Hb < 10 g/dl → refer to PHC.
Dosage:
  • Mothers (pregnant/lactating): One tablet daily containing 100 mg elemental iron (300 mg ferrous sulphate) + 0.5 mg folic acid. Continue 2-3 months after Hb returns to normal to replenish stores. Repeat Hb estimation every 3-4 months.
  • Children (6-60 months): Liquid formulation; 20 mg elemental iron (60 mg ferrous sulphate) + 0.1 mg folic acid daily for 100 days. Screening at 6 months, 1 year, and 2 years.
  • Children 6-10 years: 30 mg elemental iron + 250 mcg folic acid per day for 100 days.
  • Adolescents: Same dosage and duration as adults.

(2) Iron Fortification

  • Studies at the National Institute of Nutrition, Hyderabad showed that adding ferric ortho-phosphate or ferrous sulphate with sodium bisulphate effectively fortified salt with iron.
  • When iron-fortified salt was consumed for 12-18 months, it significantly reduced the prevalence of anaemia.
  • The Government of India accepted iron fortification of salt as a public health strategy; commercial production started in 1985.
  • Advantage over supplementation: Salt is universally consumed, so all segments of the population benefit.

(3) Other Strategies

Long-term measures applicable where prevalence and severity are lower:
  • Changing dietary habits - increasing intake of iron-rich and iron-absorption-enhancing foods
  • Control of parasites (hookworm, malaria control)
  • Nutrition education
These are considered disproportionately costly in time and resources where prevalence is very high.

National Nutritional Anaemia Prophylaxis Programme

Key features:
  • Launched during the Fourth Five Year Plan
  • Distribution of iron and folic acid (Folifar) tablets to pregnant women and young children (1-12 years)
  • Implemented through MCH Centres (urban), Primary Health Centres (rural), and ICDS projects
  • Technology for iron-fortified salt developed at National Institute of Nutrition, Hyderabad

Anaemia Mukt Bharat Programme

Under the Poshan Abhiyaan, the government's focus is on the first 1,000 days of the child (9 months of pregnancy + 6 months exclusive breastfeeding + 6 months to 2 years). Goals include:
  • Increasing birth weight
  • Reducing both IMR and MMR
  • Community-based events promoting behaviour change for maternal and child nutrition
  • Convergence with ICDS/Anganwadi centres for delivery of services

Summary Table

FeatureDetails
DefinitionHb below WHO cut-offs due to nutritional deficiency
Most common causeIron deficiency; also folate/B12
Most sensitive testSerum ferritin (< 10 mcg/L = absent iron stores)
Most prevalent stage in IndiaLatent iron deficiency (stage 2)
Hb cut-off (pregnant)< 11 g/dl
Hb cut-off (adult male)< 13 g/dl
Key at-risk groupsPregnant/lactating women, children, adolescents
Prevalence in Indian children < 3 yr72.7% urban, 81.2% rural
Maternal mortality contribution19%
National programmeNNAAPP (4th Five Year Plan)
Dose for pregnant women100 mg elemental iron + 0.5 mg folic acid/day
Dose for children (6-60 months)20 mg elemental iron + 0.1 mg folic acid/day for 100 days
  • Park's Textbook of Preventive and Social Medicine, pp. 720, 738-739

Anemia mukht bharat programme

Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
I now have all the material needed. Let me compile the complete answer.

Anaemia Mukt Bharat (AMB) Programme

Park's Textbook of Preventive and Social Medicine, p. 756

Background and Launch

The Anaemia Mukt Bharat (AMB) Programme - meaning "Anaemia-Free India" - was launched in 2018 under the POSHAN Abhiyaan (National Nutrition Mission). It was the Government of India's response to the persistently high burden of anaemia across all age groups, with iron deficiency anaemia being the most widespread micronutrient deficiency in the country.
The programme is based on a "6 x 6 x 6" framework - six beneficiary groups, six interventions, and six institutional mechanisms for delivery.

The Problem it Addresses

  • 72.7% of children under 3 years in urban areas are anaemic; 81.2% in rural areas
  • Anaemia accounts for 19% of maternal deaths in India
  • Prevalence in adolescent girls: 72.6% (DLHS 2002-04)
  • Affects women in reproductive age (15-49 yrs), children, and low socio-economic groups

Six Target Beneficiary Groups

The programme adopts a life-cycle approach through the National Iron Plus Initiative (NIPI), covering:
  1. Children under 5 years (6 months to 5 years)
  2. Children 6-10 years (school-going children)
  3. Adolescents (10-19 years) - both girls and boys
  4. Pregnant women
  5. Lactating mothers
  6. Women in Reproductive Age Group (WRA, non-pregnant)

Six Key Interventions

1. Prophylactic Iron and Folic Acid (IFA) Supplementation

Age and dose-specific IFA supplementation through the life-cycle approach:
GroupDoseFrequency
Children 6-60 months20 mg elemental iron + 0.1 mg folic acidDaily for 100 days
Children 6-10 years30 mg elemental iron + 250 mcg folic acidDaily for 100 days
Adolescents (10-19 yrs) via WIFS100 mg elemental iron + 500 mcg folic acidWeekly (fixed day approach)
Pregnant women100 mg elemental iron + 0.5 mg folic acidDaily
Lactating mothers100 mg elemental iron + 0.5 mg folic acidDaily

2. Deworming

  • Biannual deworming with Albendazole 400 mg, six months apart
  • Targets helminth/intestinal worm infestation which contributes to anaemia
  • Delivered through the National Deworming Day and school-based platforms
  • Deworming is linked with WIFS in adolescents (through the school health programme)

3. Intensified Year-Round Behaviour Change Communication (BCC) Campaign

Tagline: "Solid Body, Smart Mind"
Focuses on four key behaviours:
(a) Improving compliance to IFA supplementation and deworming
(b) Appropriate infant and young child feeding (IYCF) practices
(c) Increasing intake of iron-rich foods through:
  • Diet diversity
  • Increased quantity/frequency
  • Fortified foods
  • Harnessing locally available resources
(d) Ensuring delayed cord clamping after delivery - by 3 minutes in health facilities
  • Delayed cord clamping is associated with decreased risk of anaemia and intraventricular haemorrhage in newborns

4. Testing and Treatment of Anaemia Using Digital Methods

  • Point-of-care testing (digital Hb estimation) with emphasis on:
    • Pregnant women
    • School-going adolescents
  • Ensures early identification and prompt treatment
  • Moderate/severe anaemia cases referred to appropriate health facilities

5. Mandatory Provision of IFA-Fortified Foods in Government-Funded Programmes

  • Iron and folic acid fortified foods made mandatory in:
    • Mid-Day Meal (MDM) Programme
    • ICDS (Integrated Child Development Services)
    • PDS (Public Distribution System)
    • Other government public health nutrition programmes
  • Fortification of salt with iron (ferric ortho-phosphate or ferrous sulphate with sodium bisulphate) - technology developed at the National Institute of Nutrition, Hyderabad; commercial production began in 1985

6. Intensifying Awareness, Screening and Treatment of Non-Nutritional Causes of Anaemia

Special focus on endemic pockets for:
  • Malaria - causes or aggravates anaemia
  • Haemoglobinopathies (e.g., sickle cell disease, thalassaemia)
  • Fluorosis - endemic in parts of India

Six Institutional Delivery Mechanisms (Platforms)

The AMB strategy is implemented through existing delivery platforms under NIPI and WIFS:
  1. Anganwadi Centres (AWCs) - through ICDS, for children under 6 and pregnant/lactating women
  2. Primary Health Centres (PHCs) / Sub-Centres - for rural beneficiaries
  3. Schools - for school-going children (6-19 years) through WIFS and school health programmes
  4. Health and Wellness Centres / ASHA - for community outreach and adolescent services (ARSH clinics)
  5. Village Health and Nutrition Days (VHNDs) - monthly at Anganwadi centres
  6. MCH Centres and Government Hospitals - for pregnant/lactating women and treatment of moderate/severe anaemia

Weekly Iron and Folic Acid Supplementation (WIFS) - Key Component

Launched by MoHFW specifically for adolescents:
  • Target: Adolescent girls and boys (10-19 years); covers 10.25 crore adolescents across India
  • Dose: 100 mg elemental iron + 500 mcg folic acid, once weekly on a fixed day (supervised)
  • Long-term goal: Break the intergenerational cycle of anaemia
  • Short-term benefit: Nutritionally improved human capital
  • Rolled out in 32 states and UTs under NIPI; covered ~3 crore beneficiaries by December 2013
  • Linked with: biannual deworming, dietary counselling, and screening for moderate/severe anaemia

National Iron Plus Initiative (NIPI) - The Parent Strategy

NIPI is the overarching framework through which AMB is operationalized:
  • Life-cycle approach - continuous age-specific and dose-specific IFA supplementation
  • Covers all vulnerable age groups from infancy through reproductive age
  • AMB is implemented in all villages, blocks, and districts of all States/UTs of India through existing NIPI and WIFS delivery platforms

Focus on First 1,000 Days (Poshan Abhiyaan Context)

Under Poshan Abhiyaan, the AMB programme prioritizes the first 1,000 days of the child:
  • 9 months of pregnancy
  • 6 months of exclusive breastfeeding
  • Period from 6 months to 2 years
This focus aims to:
  • Increase birth weight
  • Reduce both IMR and MMR
  • Consolidate gains through intervention up to age 3 years
  • Further interventions for children 3-6 years through Anganwadi platforms (for overall development)

Summary: The 6x6x6 Framework at a Glance

6 Beneficiaries6 Interventions6 Delivery Platforms
Children < 5 yrsIFA supplementationAnganwadi centres
Children 6-10 yrsDewormingPHCs/Sub-centres
Adolescents (10-19)BCC - "Solid Body, Smart Mind"Schools (WIFS)
Pregnant womenPoint-of-care testing & treatmentASHA/community
Lactating mothersFortified food provisionVHNDs
WRA (non-pregnant)Non-nutritional anaemia managementMCH/hospitals
  • Park's Textbook of Preventive and Social Medicine, p. 756 (Anaemia Mukt Bharat Strategy)

QDENGA vaccine

Finding Sources
Searching PubMed

QDENGA TAK-003 dengue vaccine

Searching the Web

QDENGA dengue vaccine TAK-003 efficacy safety approval 2024 2025

Reading File
Reading File
Reading File
Reading Article

PMID: 40195054

I now have comprehensive data from multiple authoritative sources. Here is the complete, detailed answer:

QDENGA Vaccine (TAK-003)


What is QDENGA?

QDENGA (brand name) / TAK-003 (developmental code) is a live-attenuated tetravalent dengue vaccine developed by Takeda Pharmaceuticals. Its full generic name is Dengue Tetravalent Vaccine (Live, Attenuated).
It is designed to protect against all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, DENV-4).

Vaccine Platform / Mechanism

  • Type: Recombinant chimeric, live-attenuated vaccine
  • Backbone: Uses an attenuated DENV-2 virus as a genetic backbone (unlike Dengvaxia which uses the Yellow Fever 17D platform)
  • Construction: The structural protein genes (prM and E) of DENV-1, DENV-3, and DENV-4 are individually inserted into the attenuated DENV-2 backbone, creating four chimeric viruses that together make up the tetravalent formulation
  • This design means DENV-2 proteins are expressed from the "native" component while the other three serotypes are expressed as chimeras - which explains why efficacy against DENV-2 is consistently higher than against other serotypes

Schedule and Administration

ParameterDetail
No. of doses2 doses
Interval3 months apart (0 and 3 months)
RouteSubcutaneous injection
Age indication4 years and older (EU/most approvals)
Pre-vaccination serology requiredNo - can be given regardless of prior dengue exposure

Approved Indications / Regulatory Status

RegionStatus
European UnionApproved (EMA) for ages ≥4 years
BrazilApproved (ANVISA)
ThailandApproved
Indonesia, Argentina, and othersApproved in multiple countries
USA (FDA)Not yet FDA-approved for travelers
Global reach (as of 2025)18.6 million doses distributed in 11 endemic countries
QDENGA is the only approved dengue vaccine that does not require pre-vaccination serologic testing (unlike Dengvaxia/CYD-TDV).

Key Clinical Trial: TIDES (Tetravalent Immunization against Dengue Efficacy Study)

  • Phase 3, randomized, double-blind, placebo-controlled trial (DEN-301)
  • Conducted in >28,000 volunteers across 13 countries in dengue-endemic and non-endemic areas
  • Participants aged 4-16 years; programme overall studied ages 18 months to 60 years
  • Duration: 7 years of follow-up (now the longest-studied dengue vaccine trial; completed November 2025)

Efficacy Results (Pooled / TIDES)

OutcomeEfficacy
Overall vaccine efficacy (symptomatic dengue)~80% overall
Efficacy against hospitalized dengue~90%
Efficacy in seropositive individualsHigher
Efficacy in seronegative individualsModerate (overall positive; see caveats below)
Against DENV-1High
Against DENV-2Highest (native backbone)
Against DENV-3Lower (especially in seronegative); small signal of potentially increased hospitalization risk
Against DENV-4Insufficient DENV-4 infections occurred during trial to assess
4.5-year data (Lancet Global Health 2024): Confirmed sustained efficacy against symptomatic dengue and hospitalization with a favorable long-term safety profile.
7-year data (November 2025): Confirmed sustained protection through 7 years; data confirm favorable benefit-risk profile of the two-dose regimen (no booster needed).

Immunogenicity

  • Induces neutralizing antibodies against all 4 DENV serotypes
  • High seropositivity rates particularly for DENV-2
  • Antibody responses sustained at least 3 years after vaccination (systematic review, 2025 - PMID: 40195054)
  • Both seropositive and seronegative recipients mount measurable immune responses

Safety Profile

Adverse EventDetail
Common (mild)Injection site pain, erythema, swelling
SystemicHeadache, fatigue, myalgia - transient
Serious adverse eventsRare; no causal association established
Dengvaxia-type enhancement riskNot observed in seronegative individuals in completed trials
PregnancyContraindicated (live vaccine); data on unintentional exposure being collected
ImmunocompromisedCaution - live vaccine
The 7-year TIDES data reinforce QDENGA's long-term safety profile.

Comparison with Dengvaxia (CYD-TDV)

FeatureQDENGA (TAK-003)Dengvaxia (CYD-TDV)
PlatformDENV-2 backbone chimericYellow Fever 17D backbone chimeric
Doses2 (0, 3 months)3 (0, 6, 12 months)
Pre-vaccination serologyNot requiredRequired (seropositive only)
Approved age≥4 years9-45 years (seropositive only)
Use in seronegativeCan be used; some caveats for DENV-3Contraindicated - increases severe dengue risk
Serotype-specific efficacyStrongest for DENV-2More balanced but seropositive-dependent
Long-term data7 yearsAvailable
FDA approvalNot approvedApproved (seropositive, 9-16 yrs in endemic areas)

Important Limitations and Ongoing Questions

  1. DENV-3 in seronegatives: A very small signal of potentially increased hospitalization risk after DENV-3 infection was observed in seronegative recipients - under continued scrutiny
  2. DENV-4: Insufficient DENV-4 cases occurred during TIDES to fully characterize serotype-4 efficacy
  3. DENV-2 dominant efficacy: The DENV-2 backbone architecture means anti-DENV-2 immunity is most robust; questions remain about balanced protection across all 4 serotypes, especially in seronegative individuals - noted by Harrison's 2025
  4. Co-administration: Studies confirm it can be co-administered with 9-valent HPV vaccine (El Hindi et al. Vaccine, 2025)
  5. Travelers: Can be considered for use in travelers going to endemic areas, but no FDA approval yet for this indication; EU/EMA approved

WHO Recommendations

  • Introduction recommended in settings with high dengue transmission intensity to maximize public health benefit while minimizing potential risk in seronegative individuals
  • Post-market surveillance ongoing globally
  • Aligns with the existing National Iron Plus Initiative (NIPI) analogy: targeted deployment where burden is highest

Real-World Effectiveness

Brazil, 2025 (Lancet Infectious Diseases): A test-negative, case-control study of QDENGA effectiveness in adolescents during the massive 2024 São Paulo dengue outbreak confirmed significant real-world protection against symptomatic dengue - validating trial findings in a high-transmission real-world scenario.

Summary Box

FeatureQDENGA (TAK-003)
DeveloperTakeda Pharmaceuticals
TypeLive-attenuated tetravalent (recombinant chimeric)
BackboneAttenuated DENV-2
Schedule2 doses, 3 months apart
Age≥4 years
Pre-test requiredNo
Efficacy vs hospitalization~90%
Best serotype efficacyDENV-2
Longest-studied7 years (TIDES trial)
Doses distributed (2025)18.6 million in 11 countries

Disaster management from park textbook

Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Reading File
I now have all the essential content. Let me compile the comprehensive answer.

Disaster Management

Park's Textbook of Preventive and Social Medicine

Definition of Disaster

A disaster is defined as a serious disruption of the functioning of a community or society involving widespread human, material, economic, or environmental losses and impacts, which exceeds the ability of the affected community or society to cope using its own resources.
A hazard is defined as a dangerous phenomenon, substance, human activity or condition that may cause:
  • Loss of life, injury, or other health impacts
  • Property damage
  • Loss of livelihoods and services
  • Social and economic disruption
  • Environmental damage
India, due to its physiographic and climatic conditions, is one of the most disaster-prone areas in the world, with an average of 8 major natural calamities per year.

Types of Disasters

Disasters are primarily triggered by natural hazards, are human-induced, or result from a combination of both.

A. Natural Hazards

Classified into five major categories (DesInventar 2016):
  1. Geophysical - Earthquakes, volcanoes, tsunamis, mass movement (dry)
  2. Hydrological - Floods, mass movement (wet), wave action
  3. Climatological - Extreme temperature, drought, wildfire
  4. Meteorological - Storms, cyclones
  5. Biological - Epidemics, insect infestations, animal incidents

B. Human-Induced Disasters

Divided into three categories:
(a) Sudden disasters:
  • Examples: Bhopal Gas Tragedy (Dec 3, 1984) - methyl isocyanate leak, Union Carbide Pesticide Plant, ~3,000 dead, 2 million exposed
  • Chernobyl nuclear accident (April 26, 1986) - largest accidental release of radioactive material; deposited >7 million curies of iodine-131, caesium-134/137, strontium-90 across the northern hemisphere
(b) Insidious disasters:
  • Long-term chemical/radiation exposure (nuclear factories, labs releasing radioactive substances into air/soil/water)
  • Global warming (greenhouse effect) - from burning fossil fuels
  • Ozone layer depletion - chlorofluorocarbons
(c) Wars and civil conflicts:
  • Since WWII: ~127 wars, 21.8 million war-related deaths, >50% civilians
  • Chemical, Biological, Radiological, Nuclear (CBRN) disasters

Disaster Management - Definition

The UNISDR defines disaster risk management as:
"The systematic process of using administrative decisions, organizations, operational skills and capacities to implement policies, strategies and coping capacities of the society and communities to lessen the impacts of natural hazards and related environmental and technological disasters."
It comprises all forms of activities including structural and non-structural measures to:
  • Avoid (prevention)
  • Limit (mitigation and preparedness)
adverse effects of hazards.

Three Fundamental Aspects of Disaster Management

  1. Disaster Response
  2. Disaster Preparedness
  3. Disaster Mitigation
These three aspects correspond to different phases of the Disaster Cycle (Fig. 1):
Disaster Management Cycle showing Risk reduction phase (Preparedness → Mitigation) and Recovery phase (Response → Rehabilitation → Reconstruction)
Fig. 1 - Management Sequence of a Sudden-Onset Disaster (Park's Textbook)

1. Disaster Impact and Response

Search, Rescue and First Aid

  • After a major disaster, the need for search, rescue and first aid is so great that organized relief services can meet only a small fraction of demand
  • Most immediate help comes from uninjured survivors
  • Most injuries are sustained during the impact - greatest need for emergency care in the first few hours

Field Care

  • Most injured persons converge spontaneously to health facilities using available transport
  • Health service resources must be redirected to this new priority
  • Maximize bed availability and surgical services
  • Provisions for food and shelter
  • Establish a centre to respond to inquiries from patient's relatives
  • Priority to victim identification; provide adequate mortuary space

Triage

Triage is the cornerstone of mass casualty management.
Triage consists of rapidly classifying the injured on the basis of the severity of their injuries and the likelihood of their survival with prompt medical intervention.
Principle: "First come, first treated" is NOT followed in mass emergencies.
Priority system:
PriorityCategoryDescriptionColour
1Immediate (T1)Life-threatening but salvageable with simple interventionsRed
2Delayed (T2)Serious but can wait without immediate life riskYellow
3Minor (T3)Walking wounded, minor injuriesGreen
4Expectant (T4)Moribund/unsalvageable; require massive resources with questionable benefitBlack/Blue
  • Triage should be carried out at the site of disaster to determine transport priority
  • Reassessment occurs on arrival at hospital/treatment centre
  • Higher priority is granted to victims whose immediate or long-term prognosis can be dramatically affected by simple intensive care
  • Moribund patients requiring enormous attention with questionable benefit have the lowest priority
  • Persons with minor/moderate injuries should be treated at home to avoid draining resources
  • Seriously injured should be transported to hospitals with specialized treatment facilities

Tagging

All patients should be identified with tags stating:
  • Name, age, place of origin
  • Triage category
  • Diagnosis
  • Initial treatment given

Care of the Dead

  • Care of the dead is an essential part of disaster management
  • Large numbers of dead can also impede rescue activities
  • Steps: (1) Removal from scene → (2) Shift to mortuary → (3) Identification → (4) Reception of bereaved relatives
  • Health hazards from cadavers are minimal if death was from trauma
  • Bodies may contaminate water sources in floods, potentially transmitting gastroenteritis or food poisoning
  • The dead bodies represent a delicate social problem

2. Relief Phase

Begins when assistance from outside starts to reach the disaster area.
Critical health supplies needed immediately:
  • Treatment of casualties
  • Prevention of communicable diseases
Subsequent supplies needed:
  • Food, blankets, clothing, shelter
  • Sanitary engineering equipment and construction material
Four principal components in managing humanitarian supplies:
  1. Acquisition of supplies
  2. Transportation
  3. Storage
  4. Distribution
A rapid damage assessment must be carried out to identify needs and resources.

3. Epidemiologic Surveillance and Disease Control

Disasters increase transmission of communicable diseases through:
  1. Overcrowding and poor sanitation in temporary resettlements → acute respiratory infections
  2. Population displacement → introduction of communicable diseases (migrant or indigenous populations may lack immunity)
  3. Disruption and contamination of water supply, damage to sewerage and power systems
  4. Disruption of routine control programmes (funds/personnel diverted to relief work)
  5. Ecological changes favouring vector breeding and increased vector population density
  6. Displacement of domestic and wild animals carrying zoonoses (leptospirosis, rickettsiosis, rabies, equine encephalitis)
  7. Emergency food, water and shelter from new sources may themselves be sources of infection
Most common post-disaster disease: Gastroenteritis (related to water contamination, overcrowding, poor sanitation).
Principles of communicable disease control after disaster:
  • (a) Implement public health measures as soon as possible to reduce disease transmission risk
  • (b) Organize a reliable disease reporting system to identify outbreaks and initiate control measures
  • (c) Investigate all reports of disease outbreaks rapidly

Vaccination Policy After Disasters

WHO does NOT recommend mass typhoid and cholera vaccination in routine use in endemic areas post-disaster, because:
  • Mass vaccination requires large numbers of workers who could be better employed elsewhere
  • Poor supervision of sterilization and injection techniques may cause more harm than good
  • Mass vaccination creates a false sense of security and leads to neglect of effective control measures
Recommended instead: Supplying safe drinking water and proper disposal of excreta remain the most practical and effective strategies.
Tetanus: Significant increase in tetanus after natural disasters is uncommon. Mass tetanus vaccination of the population is usually unnecessary. Best protection: maintenance of high pre-existing immunity + adequate wound cleaning. A booster is indicated if immunization was >5 years ago in a patient with open wound.
Vaccinations recommended specifically for health workers.

4. Rehabilitation

The final phase - restoration of pre-disaster conditions.
Rehabilitation starts from the very first moment of a disaster.
In the first weeks, health needs shift rapidly from casualty treatment to routine primary health care, then to environmental health measures.
Key rehabilitation priorities:

Water Supply

  • Survey all public water supplies (distribution system + source)
  • Priority: chlorination (residual chlorine 0.2-0.5 mg/litre)
  • Low water pressure increases risk of pollutant infiltration into water mains
  • Protection measures for water sources: restrict access (fencing/guard), ensure safe excreta disposal at safe distances, prohibit upstream contamination activities

Food Safety

  • Poor hygiene is the major cause of food-borne disease in disaster situations
  • Kitchen sanitation is of utmost importance in shelters/camps
  • Monitor personal hygiene of food handlers

Basic Sanitation and Personal Hygiene

  • Prompt attention to excreta disposal and personal hygiene
  • Defecation fields at safe distance from living areas, water sources, and food preparation areas

5. Disaster Mitigation in Health Sector

Emergency prevention and mitigation involves measures designed to prevent hazards from causing emergencies or to lessen their effects.
Measures include:
  • Flood mitigation works
  • Appropriate land-use planning
  • Improved building codes
  • Reduction or protection of vulnerable populations and structures
The direct responsibility of the health sector in mitigation is limited to:
  • Ensuring safety of health facilities
  • Ensuring continuity of public health services (water supply, sewerage systems)

6. Disaster Preparedness

Definition: "A programme of long-term development activities whose goals are to strengthen the overall capacity and capability of a country to manage efficiently all types of emergency. It should bring about an orderly transition from relief through recovery, and back to sustained development."
Objective: Ensure that appropriate systems, procedures and resources are in place to provide prompt, effective assistance to disaster victims.

Why Community Preparedness is the Cornerstone

(a) Community members have the most to lose from vulnerability and most to gain from preparedness
(b) First responders come from within the community; external response may not arrive for days when transport/communications are disrupted
(c) Resources are most easily pooled at community level; failure to use community capabilities is poor resource management
(d) Sustained development is best achieved by allowing communities to design, manage, and implement assistance programmes themselves

Eight Key Tasks of the National Preparedness System

  1. Evaluate the risk of the country or region to disaster
  2. Adopt standards and regulations
  3. Organize communication, information and warning systems
  4. Ensure coordination and response mechanisms
  5. Adopt measures to ensure financial and other resources are available and can be mobilized
  6. Develop public education programmes
  7. Coordinate information sessions with news media
  8. Organize disaster simulation exercises that test response mechanisms

Policy Development in Disaster Preparedness

Policy "establishes long-term goals, assigns responsibilities, establishes recommended work practices, determines criteria for decision-making."
Six sectors required for response and recovery strategies:
  1. Communication
  2. Health
  3. Social welfare
  4. Police and security
  5. Search and rescue
  6. Transport

7. Man-Made Disasters - Public Health Response

The primary response is primary prevention - prevention of occurrence:
  • Tighter regulations of chemical plants and hazardous facilities
  • Build chemical plants away from densely populated areas
  • Appropriate engineering and technological measures (building codes, dam designs, containment of toxic materials)
  • Early warning systems
  • Protection against human errors

8. Disasters in India

India is the highly disaster-prone country in Asia-Pacific region, averaging 8 major natural calamities per year.
RegionDisaster Type
Northern mountains/foothillsSnowstorms, landslides, earthquakes
Eastern coastal areas (AP, WB, Odisha)Severe floods and cyclones
Bihar, Assam, UPMajor floods almost every year
Western desert areasDroughts
Notable Indian Disasters:
  • Bhopal Gas Tragedy (1984) - world's worst industrial disaster
  • Odisha Super Cyclone (29 Oct 1999)
  • Gujarat Earthquake (~16,480 deaths)
  • Indian Ocean Tsunami (Dec 2004, >200,000 deaths)
  • J&K Earthquake (7.4 RS, 2,100 dead, 30,000 injured)
  • Uttarakhand cloudburst/floods, Kedarnath (June 2013, ~5,748 dead)
  • Kashmir valley floods (2014)

Institutional Framework in India

BodyRole
Ministry of Home Affairs (MHA)Overall coordination of disaster management
Cabinet Committee on Security (CCS)Top-level decision-making
National Crisis Management Committee (NCMC)Key committee for disaster decisions
National Disaster Management Authority (NDMA)Lead agency - prepares DM plans and executes DM functions at national level
State Disaster Management Authority (SDMA)State-level disaster management
State governmentsResponsible for execution of relief work in natural disasters
Government of IndiaSupplementary financial support to states
Legal framework: The Disaster Management Act, 2005 provides for setting up of NDMA at national level and SDMA at state level.

Personal Protection Measures - General Rules (for all emergencies)

  • Do not use the telephone except to call for help (keep lines free for emergency response)
  • Listen to radio and media for official updates
  • Follow official instructions given over radio or loudspeaker
  • Keep a family emergency kit ready
Principle: "Be prepared rather than get hurt; get information to get organized; wait rather than act too hastily."

Summary: The Disaster Management Cycle

PhaseTimingKey Activities
PreparednessBefore disaster (risk reduction)Planning, training, simulation exercises, warning systems
MitigationBefore disaster (risk reduction)Flood works, building codes, land-use planning
ResponseImmediately after impactSearch & rescue, triage, first aid, relief supplies
RehabilitationWeeks after disaster (recovery)Water/sanitation restoration, primary health care
ReconstructionLong-term (recovery)Rebuilding infrastructure, sustained development
  • Park's Textbook of Preventive and Social Medicine, pp. 898-903

Rapid response team

Finding Sources
Finding Sources
This is a shared conversation. Sign in to Orris to start your own chat.